(Q37820986)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158555%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

review article

1 reference

title

The pharmacological management of violence in schizophrenia: a structured review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158555%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158555%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Seena Fazel

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158555%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Anya Topiwala

series ordinal

1

1 reference

23 August 2017

Seena Fazel

series ordinal

2

1 reference

23 August 2017

publication date

1 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158555%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158555%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158555%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158555%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

53-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21158555%20AND%20SRC:MED&resulttype=core&format=json

The population impact of severe mental illness on violent crime.

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Aggressive incidents in first-episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Schizophrenia and violence: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Rates of mental disorder in people convicted of homicide. National clinical survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Psychotic homicides in Copenhagen from 1959 to 1983.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Psychiatric morbidity among homicide offenders: a Swedish population study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Violence in inpatients with schizophrenia: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Prevalence and precipitants of aggression in psychiatric inpatient units.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Dangerous behaviour preceding first admissions for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Violence and delusions: data from the MacArthur Violence Risk Assessment Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Criminal offending in schizophrenia over a 25-year period marked by deinstitutionalization and increasing prevalence of comorbid substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Schizophrenia, substance abuse, and violent crime.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Heterogeneity of violence in schizophrenia and implications for long-term treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Antiepileptic drugs in schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Combined treatment of schizophrenic psychoses with haloperidol and valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Suicidal risk during treatment with clozapine: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

The effect of quetiapine on aggression and hostility in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Effect of Lithium on Human Aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

The long-term use of lithium in aggressive prisoners.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit/hyperactivity disorder: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostility

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

A national study of violent behavior in persons with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Effectiveness of ECT combined with risperidone against aggression in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Prevalence of substance misuse in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Violent behavior in mental illness: the role of substance abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Substance abuse and schizophrenia: pharmacotherapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Outcome measures used in forensic mental health research: a structured review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Atypical antipsychotics in the treatment of the persistently aggressive psychotic patient: methodological concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.180